The NOAH-AFNET 6 trial shows that giving a direct oral anticoagulant to patients with these device-detected arrhythmias has no benefits and increases risks.
University of Birmingham researcher seeks to reduce the damage done by chemotherapy, making cancer treatment more tolerable for children.
BiMaTs will offer a range of services including developing protocols that are specific to the needs of individual clients
Researchers have developed an artificial intelligence (AI) system with potential to identify sight-threatening eye disease and predict other health conditions.
Birmingham researchers will target Galectin-9, a protein involved in thrombo-inflammation processes.
Birmingham researchers will explore how macrophages in the placenta may contribute to the development of preeclampsia.
Patients in England are less likely to be treated during the Gov't-set 18-week referral to treatment window due to “unhelpful” target setting, new study finds.
Even moderate exposure to nicotine-free vapour causes suppression of neutrophil’s typical activity.